Fan Q W, Iosbe I, Asou H, Yanagisawa K, Michikawa M
Department of Dementia Research, National Institute for Longevity Sciences, 36-3 Gengo, Morioka, Obu, Aichi, 474-8522 Japan.
J Am Aging Assoc. 2001 Jan;24(1):1-10. doi: 10.1007/s11357-001-0001-9.
The importance of apolipoprotein E (apoE) in the central nervous system (CNS) became increasingly clear since the descovery that apoE ε4 allele is a major risk factor for Alzheimer's disease. ApoE is one of the major apolipoproteins that acts as a ligand for the cellular uptake of lipoproteins via apoE receptors, members of low-density lipoprotein receptor (LDLR) family, in the CNS. Recently, LDLR family has been shown to have new functions that modulate intracellular signalling and affect neuronal and glial functions, survival and regeneration. However, the pattern of expression of apoE receptors in the CNS has not been fully clarified yet. The LDLR, very low density lipoprotein receptor (VLDLR), LDLR-related protein (LRP), and apolipoprotein E receptor 2 (apoER2) are known to bind to and internalize apoE-containing lipoproteins. Here we summarize the expression of apoE receptors in the CNS and demonstrate additional our original data on cell type specific expression and regulation of those receptors in the CNS, using in situ hybridization and RT-PCR. The cells used in our study were highly enriched cultures of neurons, astrocytes, microglia and oligodendrocytes isolated from rat brain and neuroblastoma cell line, Neuro2a. All of these four types of receptors were shown to be expressed in neurons, astrocytes, microglia and oligodendrocytes, while LDLR and LRP were expressed in Neuro2a cells. We further examined the regulation of the expression of these receptors by altering the cholesterol content of the cells, and found that only the LDLR expression was downregulated following internalization of lipoprotein cholesterol and upregulated by cholesterol deprivation, in neuronal and astroglial cells. These data together with previous studies suggest that LDLR, VLDL, LRP, and apoER2 may be involved in apoE-mediated lipid uptake and/or intracellualr signalling in the cells of the CNS cells, i.e., neurons, astrocytes, microglia, and oligodendrocytes.
自从发现载脂蛋白E(apoE)ε4等位基因是阿尔茨海默病的主要危险因素以来,apoE在中枢神经系统(CNS)中的重要性日益明显。ApoE是主要的载脂蛋白之一,在CNS中作为脂蛋白通过apoE受体(低密度脂蛋白受体(LDLR)家族成员)进行细胞摄取的配体。最近,已表明LDLR家族具有调节细胞内信号传导并影响神经元和神经胶质细胞功能、存活及再生的新功能。然而,apoE受体在CNS中的表达模式尚未完全阐明。已知LDLR、极低密度脂蛋白受体(VLDLR)、LDLR相关蛋白(LRP)和载脂蛋白E受体2(apoER2)可结合并内化含apoE的脂蛋白。在此,我们总结了apoE受体在CNS中的表达,并使用原位杂交和逆转录聚合酶链反应(RT-PCR)展示了我们关于这些受体在CNS中细胞类型特异性表达和调控的更多原始数据。我们研究中使用的细胞是从大鼠脑和神经母细胞瘤细胞系Neuro2a分离出的高度富集的神经元、星形胶质细胞、小胶质细胞和少突胶质细胞培养物。所有这四种类型的受体均在神经元、星形胶质细胞、小胶质细胞和少突胶质细胞中表达,而LDLR和LRP在Neuro2a细胞中表达。我们通过改变细胞的胆固醇含量进一步研究了这些受体表达的调控,发现仅在神经元和星形胶质细胞中,脂蛋白胆固醇内化后LDLR表达下调,胆固醇剥夺后LDLR表达上调。这些数据与先前的研究共同表明,LDLR、VLDL、LRP和apoER2可能参与CNS细胞(即神经元、星形胶质细胞、小胶质细胞和少突胶质细胞)中apoE介导的脂质摄取和/或细胞内信号传导。